Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7225 p744
23 November 2002

This page
Reprint
Photocopy

   

PDF* 75K

Letters

  Public health
  Community pharmacy
  Pharmacy practice
  Drug tariff
  ADR reporting
  Parkinson's disease
  Anticholinesterases
  Medicines distribution
  Patient information
  Training
  CPD
  Onlooker


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Patient information

Unambiguous instructions are needed

From Mr G. J. Weaver, MRPharmS

Pharmaceutical suppliers are against photocopying patient information leaflets (PJ, 9 November, p666). Prescribers vigorously defend their right to prescribe part packs. Pharmacists are required to include PILs with dispensed medicines. We need an immediate and unambiguous instructions from the Royal Pharmaceutical Society law department on how dispensers can comply with their obligations.

To make my question more specific I include this example: Buccastem 3mg is available in packs of 50 which include one PIL with clear diagrams. I find it not uncommon to dispense three or four times from this pack.

G. J. Weaver
Bath

 

STEPHEN LUTENER, head of professional conduct, Royal Pharmaceutical Society, states:

The Medicines Control Agency has recently consulted the Royal Pharmaceutical Society and others on its proposals to introduce legislation which would permit the photocopying or downloading of patient information leaflets. This was one of a number of measures considered, which would aid compliance with the requirement that all supplies of medicines are accompanied by a PIL. Other measures being considered include encouraging prescribers to adopt patient pack quantities when writing prescriptions, and permitting “rounding” by pharmacists where amounts prescribed do not correspond with patient packs.

The Society does not believe that photocopying leaflets is a solution to the problems facing pharmacists because of professional and practical difficulties. In making our response, we have repeated our offer to the Department of Health and the Medicines Control Agency to meet to discuss ways forward, since we are all in agreement that it is necessary to provide a PIL with every medicine supplied, in order to fully inform, and therefore protect the patient.

Send your letter to The Editor

Previous Topic (Medicines distribution)
Next Topic (Training)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal